Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04350827 · ClinicalTrials.gov registry record · NA

PRP vs PRP Plus IGF for Patellar Tendinosis

A NA study of Tendinopathy and Patellar Ligament, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04350827 is a NA study of Tendinopathy and Patellar Ligament that has completed, run by Ohio State University. The registered enrollment target is 14 participants, below the 1,065-participant average among 10 other Tendinopathy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04350827, a NA study of Tendinopathy and Patellar Ligament, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosis.

Interventions

  • DEVICE Platelet Rich Plasma
  • DEVICE Platelet Rich Plasma plus IGF

Study Locations (1)

Ohio

  • The Ohio State University Sports Medicine Center - Columbus

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2020-02-25
Est. Completion 2021-10-16
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT04350827

The ClinicalTrials.gov registry entry for NCT04350827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,065-participant average among 10 other Tendinopathy trials with a reported enrollment target (99% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tendinopathy appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma is the first listed.

NCT04350827 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04350827 about?

NCT04350827 is a clinical study titled "PRP vs PRP Plus IGF for Patellar Tendinosis". The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosi...

What is the current status of trial NCT04350827?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-25. Estimated completion is 2021-10-16.

What conditions does trial NCT04350827 study?

This clinical trial studies the following conditions: Tendinopathy, Patellar Ligament, Platelet-Rich Plasma.

What interventions are being tested in trial NCT04350827?

The interventions under investigation include: Platelet Rich Plasma (DEVICE), Platelet Rich Plasma plus IGF (DEVICE).

Who is sponsoring clinical trial NCT04350827?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04350827 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tendinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.